Aeglea Bio Therapeutics Inc KOL and Patient Caregiver Webinar on Arginase 1 Deficiency - Corporate Call Transcript
Good afternoon, and welcome to the Aeglea BioTherapeutics KOL & Patient Caregiver Webinar on Arginase 1 Deficiency. (Operator Instructions) As a reminder, this call is being recorded, and a replay will be made available on the Aeglea website following the conclusion of the event.
I'd now like to turn the call over to your host, Anthony Quinn, President and Chief Executive Officer of Aeglea BioTherapeutics. Please go ahead, Anthony.
Yes. Thank you for joining us this afternoon for our KOL & Patient Caregiver Webinar on Arginase 1 Deficiency. I'm very excited about the speakers we have for you today who are experts in this rare disease as they are the ones that treat and live with arginase 1 deficiency.
Next slide. Please note that this webinar may include forward-looking statements under the Private Securities Litigation Reform Act. Actual results might differ materially from those projected in the forward-looking statements. Additional information
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |